Wave Life Sciences Ltd.
WVE | NASDAQ
$4.36
+$0.11 (+2.47%)
Sep 22, 2026, 12:28 PM ET · Market open
Market Data
Market Cap $838.44M
Enterprise Value $391.43M
Beta -1.30
Average Volume 3.43M
Shares Outstanding (Diluted) 202.1M
Shares Change YoY 23.24%
Institutional Ownership 86.30%
Exchange NASDAQ
ISIN US94352A1043
Price Performance
Price Change 1M -19.8%
Price Change 3M -29.6%
Price Change 6M -65.5%
Price Change YTD -73.3%
Price Change 1Y -38.5%
Price Change 3Y -21.9%
Price Change 5Y -31.2%
1M CAGR (ann.) -30.2%
1Y CAGR (ann.) -38.8%
5Y CAGR (ann.) -6.9%
All-Time CAGR -11.5%
Valuation
PE Ratio -3.90
Forward PE N/A
PEG Ratio 0.07
Forward PEG -0.23
PS Ratio 12.83
Forward PS 18.60
PB Ratio 1.85
P/FCF Ratio -4.50
P/Adj. FCF Ratio -3.95
P/OCF Ratio -4.67
EV/Sales 5.99
EV/EBIT -1.89
EV/EBITDA -1.98
EV/FCF -2.10
Earnings Yield -25.6%
FCF Yield -22.2%
Adj. FCF Yield -25.4%
Financial Health
Net Cash $447.01M
Total Debt $43.59M
Cash & Short-Term Investments $490.6M
Total Assets $564.78M
Current Ratio 9.99
Quick Ratio 9.99
Debt / Equity Ratio 0.10
Debt / EBITDA -0.22
Debt / FCF -0.23
OCF / Debt -4.24
Interest Coverage 0.00
Altman Z-Score 0.88
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 96.5%
Operating Profit Margin -333.4%
EBITDA Margin -302.2%
Net Profit Margin -309.7%
FCF Margin -284.9%
Adj. FCF Margin -325.1%
SBC / Revenue 40.2%
SBC Impact (per share) -14.1%
Returns
Return on Assets -36.3%
Return on Equity -50.1%
Return on Invested Capital -42.6%
Return on Capital Employed -42.9%
Return on Tangible Assets -36.3%
Historical Growth (CAGR)
Revenue CAGR 3Y 21.4%
Revenue CAGR 5Y 33.1%
Revenue CAGR 10Y 60.7%
EPS CAGR 3Y -30.5%
EPS CAGR 5Y 9.1%
EPS CAGR 10Y 18.6%
FCF CAGR 3Y -16.5%
FCF CAGR 5Y -27.7%
FCF CAGR 10Y -8.6%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 25
EPS Growth Next 3Y 2.8%
Revenue Growth Next 3Y 40.7%
Earnings Date Nov 8, 2026
EPS Estimate (next Q) -$0.33
EPS Growth Est (next Q) 3.1%
Revenue Est (next Q) $5.03M
Revenue Growth Est (next Q) -33.9%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $14
Price Target Upside 229.4%
Cash Flow
Operating Cash Flow $-184.68M
Free Cash Flow $-186.24M
Adj. Free Cash Flow $-212.51M
FCF Per Share -$0.92
OCF Per Share -$0.91
OCF/S Ratio -282.5%
Income Statement
Revenue $65.37M
Gross Profit $63.11M
Operating Income $-217.92M
EBITDA $-197.54M
Net Income $-202.47M
EPS (Diluted) -$1.09
Revenue / Employee $206.22K
Profit / Employee $-638.72K
Employees 317
Add to Watchlist
Select watchlists to add or remove WVE